Earlier research, such as a study conducted by Molteni M and colleagues in 1997, supports these findings by demonstrating that 19% and 12% of SSc patients displayed anti-TPO antibodies and anti-Tg antibodies, respectively. The gene discussed is TG; the disease is systemic sclerosis.